<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00613522</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX2006/10</org_study_id>
    <secondary_id>2007-A00382-51</secondary_id>
    <nct_id>NCT00613522</nct_id>
  </id_info>
  <brief_title>Role of Obstructive Sleep Apnea in Stroke Appearance</brief_title>
  <acronym>AVSAS</acronym>
  <official_title>Role of Nocturnal Respiratory Disorders on Ischemic Stroke Occurrence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Stroke is the third leading cause of death in industrialized countries and the first cause of&#xD;
      handicap in adults. Several stroke risk factors were identified such as high blood pressure,&#xD;
      diabetes mellitus, hypercholesterolemia or cardiac arrhythmias. Sleep respiratory disorders&#xD;
      have been found to be frequent among patients with stroke. Among them obstructive sleep apnea&#xD;
      (OSA) syndrome seems to be the most important due to its association with high blood pressure&#xD;
      and atrial fibrillation.&#xD;
&#xD;
      Stroke can be responsible of central apneas, therefore the differential diagnosis between&#xD;
      central apneas and pure OSA after stroke is sometimes difficult. The misidentification of OSA&#xD;
      can explain the poor tolerance of CPAP treatment by these patients. The purpose of the&#xD;
      present study is to investigate the association between pre-stroke OSA syndrome OSA diagnosed&#xD;
      on specific scales and confirmed by polygraphic studies and stroke occurrence.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      • Principal Objective : Investigate the association between obstructive sleep apnea diagnosed&#xD;
      and hemispheric ischemic stroke&#xD;
&#xD;
      • Secondary Objective :&#xD;
&#xD;
      Evaluate the relation between obstructive sleep apnea and:&#xD;
&#xD;
        -  stroke mechanisms&#xD;
&#xD;
        -  stroke prognosis&#xD;
&#xD;
        -  post-stroke tolerance to CPAP treatment.&#xD;
&#xD;
             -  Study design :&#xD;
&#xD;
      Prospective case-control study&#xD;
&#xD;
      • Inclusion criteria :&#xD;
&#xD;
      Patients (150):&#xD;
&#xD;
      Fist ischaemic hemispheric stroke or TIA Age: 50 to 90 French native speaker Able to answer&#xD;
      the questions&#xD;
&#xD;
      Controls (600):&#xD;
&#xD;
      Age: 50 to 90 French native speaker Able to answer the questions&#xD;
&#xD;
      • Exclusion criteria : Patients Haemorrhagic stroke Stroke of the brainstem Past medical&#xD;
      history of ischaemic stroke Dementia Confusion Unable to give his informed consent&#xD;
&#xD;
      Controls:&#xD;
&#xD;
      Past medical history of ischaemic stroke Dementia Confusion Unable to give his informed&#xD;
      consent&#xD;
&#xD;
      • Study plan: Cases will be recruited in the stroke unit of the Pr Orgogozo at the Bordeaux&#xD;
      University hospital. After verification of inclusion and exclusion criteria Berlin scale will&#xD;
      be measured. A polygraphic study will be performed to patients with a Berlin scale &gt; 2.&#xD;
      Patients stroke characteristics will be recorded (initial severity, stroke mechanism) at&#xD;
      baseline and stroke outcome will be evaluated at 3 months (stroke recurrence and functional&#xD;
      outcome).&#xD;
&#xD;
      Controls will be recruited among sex and age matched patients hospitalized at the&#xD;
      Bordeaux-University hospital for investigation of non-vascular disorder. After verification&#xD;
      of inclusion and exclusion criteria Berlin scale will be measured. A polygraphic study will&#xD;
      be performed to subjects with a Berlin scale &gt; 2. Controls will be evaluated at 3 months&#xD;
      using a phone interview&#xD;
&#xD;
      • Number of subjects : 150 cases and 600 controls&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Stroke recurrence</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke outcome (Rankin, Barthel) Stroke mechanism CPAP tolerance</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">289</enrollment>
  <condition>Stroke</condition>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>case</arm_group_label>
    <description>Fist ischaemic hemispheric stroke or TIA</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <description>No ischaemic hemispheric stroke or TIA</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>polygraphic study</intervention_name>
    <description>Berlin scale will be measured. A polygraphic study will be performed to subjects with a Berlin scale &gt; 2.&#xD;
Patients stroke characteristics will be recorded (initial severity, stroke mechanism) at baseline and stroke outcome will be evaluated at 3 months (stroke recurrence and functional outcome).&#xD;
Controls will be evaluated at 3 months using a phone interview</description>
    <arm_group_label>case</arm_group_label>
    <arm_group_label>control</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cases will be recruited in the stroke unit at the Bordeaux University hospital Controls&#xD;
        will be recruited among sex and age matched patients hospitalized at the&#xD;
        Bordeaux-University hospital for investigation of non-vascular disorder&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria (patients) :&#xD;
&#xD;
          -  Fist ischaemic hemispheric stroke or TIA&#xD;
&#xD;
          -  Age: 50 to 90&#xD;
&#xD;
          -  French native speaker&#xD;
&#xD;
          -  Able to answer the questions&#xD;
&#xD;
        Inclusion criteria (Controls):&#xD;
&#xD;
          -  Age: 50 to 90&#xD;
&#xD;
          -  French native speaker&#xD;
&#xD;
          -  Able to answer the questions&#xD;
&#xD;
        Exclusion criteria (patients):&#xD;
&#xD;
          -  Haemorrhagic stroke&#xD;
&#xD;
          -  Stroke of the brainstem&#xD;
&#xD;
          -  Past medical history of ischaemic stroke&#xD;
&#xD;
          -  Dementia&#xD;
&#xD;
          -  Confusion&#xD;
&#xD;
          -  Unable to give his informed consent&#xD;
&#xD;
        Exclusion criteria (Controls):&#xD;
&#xD;
          -  Past medical history of ischaemic stroke&#xD;
&#xD;
          -  Dementia&#xD;
&#xD;
          -  Confusion&#xD;
&#xD;
          -  Unable to give his informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Marc ORGOGOZO, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Groupe Hospitalier Pellegrin - Place Amélie Raba Léon</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>January 30, 2008</study_first_submitted>
  <study_first_submitted_qc>January 30, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2008</study_first_posted>
  <last_update_submitted>March 4, 2015</last_update_submitted>
  <last_update_submitted_qc>March 4, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sleep apnea, Berlin, Stroke</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

